BlossomHill Therapeutics, Inc.
BLSM
Last
$17.48
Day
+3.6%
1y
—
5y
—
52w
—
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1636d
EMA 21
—
EMA 50
—
EMA 200
—
20d high
—
5y high
—
5y range
—
Positions held
Your positionsBLSM isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
—
Hold
—
Signal
—
Target
—
Stop
—
Stop distance
—
Target vs last
—
Fundamentals
| Market cap | $536.53M | Enterprise value | $721.35M | Trailing P/E | — | Forward P/E | -4.27 |
| PEG | — | Price / book | -0.27 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | 0.28 |
| Current ratio | 5.42 | Free cash flow | — | Analyst recommendation | strong_buy | Mean target | $35.40 |
| 52w high | $27.99 | 52w low | $15.25 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$23.8M | -$21.0M | -$13.2M | -$10.5M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$24.7M | -$22.1M | -$14.1M | -$11.5M |
Yearly (6y)
| 2025 | 2024 | |
|---|---|---|
| Revenue | $0.0M | $0.0M |
| Op margin | — | — |
| Net income | -$60.6M | -$30.7M |
| Gross margin | — | — |
| Gross profit | — | — |
| Operating income | -$64.0M | -$36.4M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-18 · BlossomHill Therapeutics Q2 Loss Widens
2026-09-18 · BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results
2026-09-15 · BlossomHill Therapeutics Shares Rise 4.4% After BH-30643 Trial Update
2026-09-15 · BlossomHill Drug Shows 45% Response Rate in Lung Cancer Trial
2026-08-31 · Insiders Are Betting Big on These 3 Healthcare Stocks
Price (daily)
Full chart · RSI · MACD · patternsNo price history yet for BLSM.
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin